Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00476307
Status:
COMPLETED
Last Update Posted:
2016-11-04
First Post:
2007-05-21
Brief Title:
Immunogenicity and Reactogenicity of Fluarix Influsplit SSW 20072008 in People 18 Years Old or Above
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix Influsplit SSW 20072008 in People Aged 18 Years or Above
Status:
COMPLETED
Status Verified Date:
2016-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to test the immunogenicity and reactogenicity of the FluarixInflusplit SSW containing the influenza strains recommended for the 2007-2008 season
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None